Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 7-methylxanthine, 7-(13)c-labeled
1. 552-62-5
2. Heteroxanthine
3. Heteroxanthin
4. 7-methylxanthin
5. 2,6-dihydroxy-7-methylpurine
6. 7-methyl-3h-purine-2,6-dione
7. 7-methyl-1h-purine-2,6(3h,7h)-dione
8. Xanthine, 7-methyl-
9. 1h-purine-2,6-dione, 3,7-dihydro-7-methyl-
10. 7-methyl Xanthine
11. 3,7-dihydro-7-methyl-1h-purine-2,6-dione
12. 7-methyl-3,7-dihydro-1h-purine-2,6-dione
13. Methyl Xanthine
14. Nsc 7861
15. Ccris 5818
16. Nsc-7861
17. Einecs 209-019-0
18. Mfcd00037979
19. Unii-e9m81njm6g
20. E9m81njm6g
21. 7-methyl-2,3,6,7-tetrahydro-1h-purine-2,6-dione
22. Chembl321248
23. Chebi:48991
24. 7-methylx
25. 3,3-difluorobenzophenone
26. 7-methyl-2,6-dioxypurin
27. D04rkw
28. Methylxanthine, 7-
29. Schembl235130
30. Methyl Xanthine [inci]
31. 7-mx
32. 7-methyl-7h-purine-2,6-diol
33. Bdbm82522
34. Dtxsid60203696
35. Nsc7861
36. Pdsp1_001040
37. Pdsp2_001024
38. Wln: T56 Bn Dn Fmvmvj B1
39. Akos015903147
40. Cs-w017879
41. Hy-w017163
42. 1h-purine-2, 3,7-dihydro-7-methyl-
43. 7-methylxanthine, >=98.0% (hplc)
44. As-56812
45. Cas_552-62-5
46. Ls-162545
47. Ft-0672370
48. Adenosine Receptor Antagonist (myopia), Trier
49. En300-393798
50. 2-hydroxy-7-methyl-6,7-dihydro-1h-purin-6-one
51. Q27121426
| Molecular Weight | 166.14 g/mol |
|---|---|
| Molecular Formula | C6H6N4O2 |
| XLogP3 | -0.9 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 0 |
| Exact Mass | g/mol |
| Monoisotopic Mass | g/mol |
| Topological Polar Surface Area | 76 |
| Heavy Atom Count | 12 |
| Formal Charge | 0 |
| Complexity | 242 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
7-Methylxanthine is a known human metabolite of theobromine.
S73 | METXBIODB | Metabolite Reaction Database from BioTransformer | DOI:10.5281/zenodo.4056560
ABOUT THIS PAGE
76
PharmaCompass offers a list of 7-Methylxanthine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right 7-Methylxanthine manufacturer or 7-Methylxanthine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred 7-Methylxanthine manufacturer or 7-Methylxanthine supplier.
A methyl xanthine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of methyl xanthine, including repackagers and relabelers. The FDA regulates methyl xanthine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. methyl xanthine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A methyl xanthine supplier is an individual or a company that provides methyl xanthine active pharmaceutical ingredient (API) or methyl xanthine finished formulations upon request. The methyl xanthine suppliers may include methyl xanthine API manufacturers, exporters, distributors and traders.
methyl xanthine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of methyl xanthine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right methyl xanthine GMP manufacturer or methyl xanthine GMP API supplier for your needs.
A methyl xanthine CoA (Certificate of Analysis) is a formal document that attests to methyl xanthine's compliance with methyl xanthine specifications and serves as a tool for batch-level quality control.
methyl xanthine CoA mostly includes findings from lab analyses of a specific batch. For each methyl xanthine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
methyl xanthine may be tested according to a variety of international standards, such as European Pharmacopoeia (methyl xanthine EP), methyl xanthine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (methyl xanthine USP).
